Naseem Cassim to Cost-Benefit Analysis
This is a "connection" page, showing publications Naseem Cassim has written about Cost-Benefit Analysis.
Connection Strength
0,596
-
Estimating implementation and operational costs of an integrated tiered CD4 service including laboratory and point of care testing in a remote health district in South Africa. PLoS One. 2014; 9(12):e115420.
Score: 0,421
-
Establishing a cost-per-result of laboratory-based, reflex Cryptococcal antigenaemia screening (CrAg) in HIV+ patients with CD4 counts less than 100 cells/µl using a Lateral Flow Assay (LFA) at a typical busy CD4 laboratory in South Africa. PLoS One. 2017; 12(2):e0171675.
Score: 0,122
-
Ten-year health impact, economic impact and return on investment of the South African molecular diagnostics programme for HIV, tuberculosis and SARS-CoV-2. BMJ Glob Health. 2024 Dec 03; 9(12).
Score: 0,053